$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
AbbVie Inc. (NYSE:ABBV) Shares Sold by Reilly Financial Advisors LLC
01:42pm, Thursday, 02'nd Dec 2021 Dakota Financial News
Reilly Financial Advisors LLC lowered its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 3.3% in the third quarter, Holdings Channel reports. The firm owned 4,673 shares of the companys stock after selling 157 shares during the quarter. Reilly Financial Advisors LLCs holdings in AbbVie were worth $504,000 as of its most recent filing with []
Global Nanoemulsion Market potential Segments Their Contribution To Market Size -Allergan plc, AbbVie Inc., AstraZeneca Inc.
11:49am, Thursday, 02'nd Dec 2021 OpenPR
The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Nanoemulsion market. It sheds light on how the global Nanoemulsion Market is expected to grow during the course of the
Growing Industry of Neurosarcoidosis Treatment Market 2021-2027 | Estimated to Reach High CAGR | Top Key Players Pfizer, Vintage Labs, Allergan, AbbVie, Roche
10:06am, Thursday, 02'nd Dec 2021 OpenPR
Overview of the Global Neurosarcoidosis Treatment Market: Neurosarcoidosis Treatment Market survey report is a great backbone for the expansion of Healthcare industry. Myriad of business challenges can be quickly and easily conquered with this market research report. This market document deals with
CENTRAL TRUST Co Increases Stake in AbbVie Inc. (NYSE:ABBV)
03:28pm, Wednesday, 01'st Dec 2021 Dakota Financial News
CENTRAL TRUST Co grew its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 1.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 263,368 shares of the companys stock after acquiring an additional 5,019 shares during the quarter. AbbVie comprises 1.0% []
Dermatological Products Market Seeking Excellent Growth with GSK, Pfizer, AbbVie, DermaPharm
02:41pm, Wednesday, 01'st Dec 2021 OpenPR
HTF MI introduce new research on Dermatological Products covering micro level of analysis by competitors and key business segments. The Dermatological Products explores comprehensive study on various segments like opportunities, size, development, innovation, sales and overall growth of major players.
AbbVie seeks EMA approval for risankizumab (Skyrizi) to treat moderate to severe Crohns disease
11:40am, Wednesday, 01'st Dec 2021 Pharmaceutical Business Review
An interleukin-23 (IL-23) inhibitor, Risankizumab is intended to treat patients with Crohns disease who have shown insufficient response, lost response or are intolerant to biologic or conventional treatment. The post AbbVie seeks EMA approval for risankizumab (Skyrizi) to treat moderate to severe Crohns disease appeared first on Pharmaceutical Business review .
Worldwide Inhalation Anesthesia Industry to 2026 - Featuring Abbvie, Baxter International and Merck Among Others - ResearchAndMarkets.com
10:50am, Wednesday, 01'st Dec 2021 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Inhalation Anesthesia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global inhalation anesthesia market exhibited moderate growth during 2015-2020. Looking forward, the publisher expects the market to grow at a CAGR of around 5% during 2021-2026. Companies Mentioned Abbvie Inc. Baxter International Inc. Fresenius SE & Co. KGaA Halocarbon Products Corporati
Wendell David Associates Inc. Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)
07:38pm, Tuesday, 30'th Nov 2021 Transcript Daily
Wendell David Associates Inc. lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 1.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,413 shares of the companys stock after purchasing an additional 1,713 shares during the quarter. AbbVie accounts for []
Cancer Stem Cells Market May Set Huge Growth by 2027 | Thermo Fisher Scientific, Abbvie, Merck Kgaa
03:52pm, Tuesday, 30'th Nov 2021 OpenPR
The rising instances of various variations of cancer among individuals have been the essential justification behind the development of the worldwide cancer stem cells market. There have been a few endeavors by associations to lessen the quantity of malignant growth
RFG Advisory LLC Buys 2,989 Shares of AbbVie Inc. (NYSE:ABBV)
02:46pm, Tuesday, 30'th Nov 2021 Dakota Financial News
RFG Advisory LLC increased its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 10.2% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 32,298 shares of the companys stock after acquiring an additional 2,989 shares during the period. RFG Advisory LLCs holdings in AbbVie were worth $3,484,000 as of its most recent SEC filing. A []
Global Regenerative Medicine Market to Touch USD 167500.0 Million by 2029; Increasing Incidences of Cancer and Other Chronic Diseases to Create Opportunities for Market Growth
01:56pm, Tuesday, 30'th Nov 2021 Intrado Digital Media
Key Companies Covered in the Regenerative Medicine Market Research Report Are Amgen Inc., Novartis AG, Medtronic Plc., Stryker Corporation, CryoLife, Inc., Integra LifeSciences Corporation, 3M Company, AbbVie Inc., Zimmer Biomet, and other key market players. Key Companies Covered in the Regenerative Medicine Market Research Report Are Amgen Inc., Novartis AG, Medtronic Plc., Stryker Corporation, CryoLife, Inc., Integra LifeSciences Corporation, 3M Company, AbbVie Inc., Zimmer Biomet, and other key market players.
AbbVie submits risankizumab application to EMA in Crohn''s disease
01:11pm, Tuesday, 30'th Nov 2021 Seeking Alpha
Inflammation is a process by which your body''s white blood cells and the things they make protect you from infection from outside invaders, such as bacteria and viruses. Although it is not proven that inflammation causes cardiovascular disease, inflammation is
Autism spectrum disorder (ASD) is a neurological and developmental disorder that begins early in childhood and lasts throughout a person''s life. It affects how a person acts and interacts with others, communicates, and learns. It includes what used to be
Cytotoxic Drug Market Incredible Growth USD 20.14 million with Lonza Group, GlaxoSmithKline plc, AbbVie Inc., Sanofi, F. Hoffmann-La Roche AG
09:26am, Tuesday, 30'th Nov 2021 OpenPR
Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid
Sign In
Buy ABBV